NCT01758185View on ClinicalTrials.gov

Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

3,308

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
BIOLOGICAL

recombinant hepatitis b vaccine

0.5ml intramuscular

BIOLOGICAL

Aleph influenza vaccine

0.5ml intramuscular

Trial Locations (2)

Unknown

Xinglong County Center for Disease Control and Prevention, Zhangjiakou

Zhuolu County Center for Disease Control and Prevention, Zhangjiakou

All Listed Sponsors
lead

Beijing Center for Disease Control and Prevention

OTHER_GOV

NCT01758185 - Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine | Biotech Hunter | Biotech Hunter